The Schedule

Session I: Framing the Challenge

Chair: Prof. Ruchi Anand

9:30 – 9:40 am

Prof. Ashutosh Kumar (Professor-in-Charge, WRCB) – Welcome note and formal start of the session

9:40 – 9:55 am

Prof. Ruchi Anand (Head, Dept. of Chemistry, IITB) – Introduction and context setting for the discussions to follow

9:55 – 10:10 am

Dr. Dattatray Pawar (GM & Head of Medical Affairs, Alkem Laboratories) – Opportunities and challenges for the pharmaceutical industry in India

10:10 – 10:25 am

Dr. Kamini Walia (Senior Scientist, ICMR; Coordinator, ICMR’s AMR initiative) – Tackling AMR in India: Challenges and government initiatives/funding

10:25 – 10:40 am

Dr. Shalabh Mallik (Technical Director – Microbiology, Dr. Lal PathLabs) – Transforming AMR detection: Innovations and challenges for diagnostic labs in India

10:40 – 10:55 am

Dr. Aditi Jain (ASM Journals) – Insights from the recent international AMR conference hosted by ASM in India

10:55 – 11:00 am

Prof. Ruchi Anand (Head, Dept. of Chemistry, IITB) – Session summary

11:00 – 11:20 am

Tea Break

Session II: Ongoing research and Innovation

Chair: Prof. Kiran Kondabagil

11:20 – 11:40 am

Dr. Vasan K. Sambandamurthy (Senior VP, Bugworks Research) – Turning the Tide on Superbugs: India’s Innovation Story with BWC0977

11:40 – 12:00 pm

Prof. Kiran Kondabagil (Dept. of BSBE, IITB) – Recent breakthroughs and novel therapeutic development in AMR

12:00 – 12:35 pm

Dr. Sunil Gupta (Amneal) & Dr. Sachin Bhagwat (Wockhardt Research Centre) – Developing Zaynich: India’s breakthrough antibiotic against superbugs

12:35 – 12:55 pm

Dr. Anirvan Chatterjee (Founder/CEO, HaystackAnalytics) – Breakthroughs in detection: Haystack’s perspective

12:55 – 1:00 pm

Prof. Kiran Kondabagil (Dept. of BSBE, IITB) – Session summary

1:00 – 2:00 pm

Lunch Break

Session III:  AMR Roundtable with stakeholder from every domain 

Moderated by Dr. Savita Ayyar 

2:00 – 2:10 pm

Dr. Vinay Nandicoori (Director, CCMB) – The AMR Reality Check: Science, Surveillance, and Systemic Gaps

2:10 – 2:20 pm

Dr. Maneesh Paul (CEO, Microvioma) – Catalyzing Innovation: Rebuilding the antimicrobial discovery and delivery pipeline

2:20 – 2:30 pm

Dr. Shalabh Mallik & Dr. Anirvan Chatterjee – Diagnostics as the first line of defense: Technology, adoption, and integration

2:30 – 2:40 pm

Dr. Bharat Somani & Dr. Maneesh Paul – From policy to practice: Aligning regulation, incentives, and stewardship

2:40 – 2:50 pm

Dr. Pragya Yadav (India’s One Health Initiative) – Operationalizing One Health: Connecting human, animal, and environmental action

2:50 – 3:00 pm

Prof. Siddharth Chopra & Prof. Narendra Kumar – Building the AMR Workforce: Bridging academia, industry, and public health

Session IV: Translating AMR research into practice: Barriers & Bridges

Moderated by Prof. Ashutosh Kumar

Perspectives from clinicians from Hinduja Hospital, Fortis and IITB hospital: Current challenges in a clinical setting and a clinician's perspective on the needs of the hour to manage AMR

Session V: Towards the AMR 2035 Roadmap for India

Chair: Prof. Venkateshwarlu Yarlagadda

4:00 – 4:15 pm

Prof. Amit Singh (CIDR & Dept. of Microbiology and Cell Biology, IISc) – Translating Redox Biology into TB Therapeutic Leads

4:15 – 4:30 pm

Dr. Pragya Yadav (Former ICMR; One Health Initiative) – Opportunities through India’s One Health Initiative

4:30 – 4:45 pm

Prof. Narendra Kumar (CBMR, Lucknow) – Summarizing India’s research landscape on rapid AMR diagnosis and collaborative opportunities

4:45 – 5:00 pm

Prof. Venkateswarlu Yarlagadda (Dept. of Chemistry, IITB) – Research in next-generation antibiotics

5:00 – 5:15 pm

Saurabh Mamtani (India Health Fund) & Dr. Savita Aiyyar – Funding and capacity-building opportunities in AMR research

Closing remarks

5:15 – 5:25 pm

Prof. Ashutosh Kumar (Dept. of BSBE, IITB) – Roadmap for the future: WRCB & IITB’s commitment to AMR research; Closing remarks